-
Partnership to revolutionise RNA production
europeanpharmaceuticalreview
July 01, 2021
Under a strategic collaboration eTheRNA immunotherapies and Quantoom Biosciences will develop a novel, scalable RNA production system.
-
Remove barriers restricting the research of controlled drugs, says RPS
pharmatimes
May 17, 2021
The Royal Pharmaceutical Society (RPS) has called for changes to allow for the unrestricted, legitimate research of controlled drugs in response to a consultation from the Advisory Council on the Misuse of Drugs (ACMD).
-
RPS makes new recommendations for pharmacist independent prescribers
pharmatimes
April 28, 2021
The Royal Pharmaceutical Society of Great Britain (RPS) has made new recommendations to increase the use of pharmacist independent prescribers (PIP) in the UK.
-
RPS in discussions with government to improve patient access to medicines
pharmatimes
December 08, 2020
The Royal Pharmaceutical Society (RPS) has met with government officials to discuss changes in legislation that would enable pharmacists to make minor changes to prescriptions.
-
Over half of pharmacists report that COVID-19 has impacted their mental health
pharmatimes
November 25, 2020
A new survey published by the Royal Pharmaceutical Society (RPS) in partnership with Pharmacist report has revealed the impact of COVID-19 on pharmacists’ mental health and wellbeing.
-
RPS calls for prevention of counterfeit medicines in UK’s supply chain
pharmatimes
October 15, 2020
The Royal Pharmaceutical Society of Great Britain (RPS) has called on the UK government to take immediate action to fight counterfeit medicines from entering the country following the UK’s exit from the European Union.
-
Pharmacists should have greater powers to ensure meds access, says RPS
pharmatimes
May 20, 2020
The Royal Pharmaceutical Society (RPS) is calling for a change in medicines legislation that would allow community pharmacists to alter prescriptions to help minimise unnecessary treatment delays.